CD36 and metabolic dysfunction-associated steatotic liver disease: An increase in CD36 expression was also observed in HFD-induced NAFLD mice, and hepatocyte-specific disruption of CD36 attenuated fatty liver and improved insulin sensitivity in these mice [53].